Dr. Chava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
Bh 634
New Orleans, LA 70121Phone+1 504-842-3260Fax+1 504-842-3193
Summary
- Dr. Pavan Chava is an endocrinologist in New Orleans, LA and is affiliated with Ochsner Medical Center. He received his medical degree from Nova Southeastern University - College of Osteopathic Medicine and has been in practice 13 years. He specializes in diabetes, lipid metabolism, and thyroid and is experienced in hypoglycemia. He has 4 publications and over 50 citings.
Education & Training
- Ochsner Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
- Ochsner Clinic FoundationResidency, Internal Medicine, 2004 - 2007
- Nova Southeastern University College of Osteopathic MedicineClass of 2004
Certifications & Licensure
- LA State License 2006 - 2025
- MS State License 2020 - 2025
- AL State License 2021 - 2024
- FL State License 2020 - 2022
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 6 citationsImproving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study.Richard V. Milani, Pavan Chava, Jonathan K. Wilt, Jonathan Entwisle, Susan L. Karam
JMIR Diabetes. 2021-06-10 - 18 citationsRationale for a titratable fixed-ratio co-formulation of a basal insulin analog and a glucagon-like peptide 1 receptor agonist in patients with type 2 diabetes.Lawrence Blonde, John E. Anderson, Pavan Chava, Jared A. Dendy
Current Medical Research and Opinion. 2019-05-01 - 17 citationsAchievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical PracticeLawrence Blonde, Stephen A. Brunton, Pavan Chava, Rong Zhou, Juliana Meyers
Diabetes Spectrum. 2019-05-01
Press Mentions
- At Ochsner, Innovation Happens Inside and Outside System’s WallsDecember 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: